Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4 Aminosalicylic Acid
2. 4-aminosalicylic Acid
3. Acid, Aminosalicylic
4. Alumino 4 Aminosalicylic Acid
5. Alumino-4-aminosalicylic Acid
6. Aminosalicylic Acid
7. P Aminosalicylic Acid
8. P Aminosalicylic Acid Monolithium Salt
9. P Aminosalicylic Acid Monopotassium Salt
10. P Aminosalicylic Acid Monosodium Salt
11. P-aminosalicylic Acid
12. P-aminosalicylic Acid Monolithium Salt
13. P-aminosalicylic Acid Monopotassium Salt
14. P-aminosalicylic Acid Monosodium Salt
15. P-aminosalicylic Acid, Aluminum (2:1) Salt
16. P-aminosalicylic Acid, Calcium (2:1) Salt
17. P-aminosalicylic Acid, Monosodium Salt, Dihydrate
18. Pamisyl
19. Para Aminosalicylic Acid
20. Para-aminosalicylic Acid
21. Rezipas
1. 6018-19-5
2. Parasal Sodium
3. Sodium 4-amino-2-hydroxybenzoate Dihydrate
4. Sodium Aminosalicylate
5. Pamisyl Sodium
6. Aminosalicylate Sodium
7. Teebacin
8. 4-aminosalicylic Acid Sodium Salt Dihydrate
9. Benzoic Acid, 4-amino-2-hydroxy-, Monosodium Salt, Dihydrate
10. Aminacyl
11. Nemasol Sodium
12. Paramisan Sodium
13. Sodium 4-aminosalicylate (dihydrate)
14. Sodium Aminosalicylate Dihydrate
15. 4-amino-salicylic Acid Sodium Salt
16. Para-aminosodium Salicylate
17. Monosodium 4-aminosalicylate Dihydrate
18. S38b9w6axw
19. Aminosalicylate Sodium [usp]
20. P-aminosalicylic Acid Sodium Salt Dihydrate
21. Nsc-755862
22. Sodium;4-amino-2-hydroxybenzoate;dihydrate
23. 4-aminosalicylic Acid (sodium Salt Dihydrate)
24. Aminosalicylate Sodium (usp)
25. Sodium P.a.s.
26. P.a.s. Sodium
27. Unii-s38b9w6axw
28. Mfcd00151044
29. Parasal Sodium (tn)
30. Aminosalyle Sodium
31. Aminosalicylate Sodium Dihydrate
32. Natrium-p-aminosalicylatdihydrat
33. Sodium4-aminosalicylatedihydrate
34. Chembl2096646
35. Dtxsid5036638
36. Hy-i0447a
37. Sodium P Aminosalicylate Dihydrate
38. Sodium P-aminosalicylate Dihydrate
39. Cs-m3079
40. Aminosalicylate Sodium [vandf]
41. P-aminosalicylic Acid Monosodium Salt
42. Akos024258376
43. Nsc 755862
44. As-11771
45. Para-aminosodium Salicylate [vandf]
46. Aminosalicylate Sodium [orange Book]
47. P-aminosalicylate Acid Sodium Salt Dihydrate
48. Aminosalicylate Sodium [usp Impurity]
49. Ft-0617611
50. Sodium 4-azanyl-2-oxidanyl-benzoate Dihydrate
51. D00875
52. D78312
53. Sodium Aminosalicylate Dihydrate [vandf]
54. Beta-d-ribopyranose1,2,3,4-tetraacetate
55. Sodium Aminosalicylate Dihydrate [mart.]
56. Sodium Aminosalicylate Dihydrate [who-dd]
57. A832630
58. Neopasalate Component Aminosalicylate Sodium
59. Sodium 4-aminosalicylate Dihydrate, >=97.0% (t)
60. Aminosalicylate Sodium Component Of Neopasalate
61. Q27288525
62. Sodium Aminosalicylate Dihydrate [ep Monograph]
63. F1905-7110
64. P-aminosalicylic Acid Sodium Salt Dihydrate [mi]
65. Sodium Aminosalicylate Dihydrate For Equipment Qualification
66. Benzoic Acid, 4-amino-2-hydroxy-, Sodium Salt, Hydrate (1:1:2)
67. Sodium Aminosalicylate Dihydrate, European Pharmacopoeia (ep) Reference Standard
68. Sodium Aminosalicylate Dihydrate For Equipment Qualification, European Pharmacopoeia (ep) Reference Standard
69. Sodium Aminosalicylate Dihydrate, Pharmaceutical Secondary Standard; Certified Reference Material
Molecular Weight | 211.15 g/mol |
---|---|
Molecular Formula | C7H10NNaO5 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 1 |
Exact Mass | 211.04566670 g/mol |
Monoisotopic Mass | 211.04566670 g/mol |
Topological Polar Surface Area | 88.4 Ų |
Heavy Atom Count | 14 |
Formal Charge | 0 |
Complexity | 165 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 4 |
Antitubercular Agents
Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. (See all compounds classified as Antitubercular Agents.)
J - Antiinfectives for systemic use
J04 - Antimycobacterials
J04A - Drugs for treatment of tuberculosis
J04AA - Aminosalicylic acid and derivatives
J04AA02 - Sodium aminosalicylate
Market Place
ABOUT THIS PAGE
A 6018-19-5 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 6018-19-5, including repackagers and relabelers. The FDA regulates 6018-19-5 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 6018-19-5 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 6018-19-5 supplier is an individual or a company that provides 6018-19-5 active pharmaceutical ingredient (API) or 6018-19-5 finished formulations upon request. The 6018-19-5 suppliers may include 6018-19-5 API manufacturers, exporters, distributors and traders.
6018-19-5 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 6018-19-5 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 6018-19-5 GMP manufacturer or 6018-19-5 GMP API supplier for your needs.
A 6018-19-5 CoA (Certificate of Analysis) is a formal document that attests to 6018-19-5's compliance with 6018-19-5 specifications and serves as a tool for batch-level quality control.
6018-19-5 CoA mostly includes findings from lab analyses of a specific batch. For each 6018-19-5 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
6018-19-5 may be tested according to a variety of international standards, such as European Pharmacopoeia (6018-19-5 EP), 6018-19-5 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (6018-19-5 USP).
LOOKING FOR A SUPPLIER?